二-(2-羟基-5-长链烷基苯基)-甲烷的合成

以脂肪酸、苯酚为原料, 经酰化反应、酯化反应、Fries重排、黄鸣龙还原等步骤, 得到正构长链烷基酚, 再与多聚甲醛在酸性催化剂下进行缩合反应, 生成二-(2-羟基-5-长链烷基苯基)-甲烷, 用核磁共振氢谱和碳谱、红外光谱和元素分析对产物进行了结构鉴定. 据上述反应路线, 以工业品壬基酚和多聚甲醛为原料, 合成出了二-(2-羟基-5-壬基苯基)-甲烷, 并对其工艺条件进行了研究. 结果表明, 选用草酸作催化剂, 烷基酚和甲醛物质的量比为2∶1, 130 ℃反应4 h, 产物产率达到60%, 且反应转化率和选择性分别为63%和95%.     

新型氯苯基卟啉-5-氟尿嘧啶的合成

以3,4-二氯苯甲醛、对羟基苯甲醛,吡咯和1,5-二溴戊烷(或1,6-二溴己烷)为原料,经两步反应合成了溴烷氧基氯苯基卟啉(2a或2b);2与5-氟尿嘧啶反应,合成了两种新型的氯代苯基卟啉-5-氟尿嘧啶[1a(产率28.26%)和1b(产率29.34%)],其结构经UV-Vis,~1H NMR,IR和MS表征.     

双(对-氨基苯基)-2,3,7,8,12,13,17,18-八甲基卟啉及其金属衍生物的合成与表征

从3-甲基-2,4-戊二酮出发,经多步反应合成了3,3′,4,4′-四-甲基-2,2′-二吡咯基甲烷(TMDPM),改进了合成TMDPM的脱羧反应.研究了TMDPM与对-硝基苯甲醛反应合成meso-5,15-双-苯基-卟啉反应,发现对-甲基苯磺酸是卟啉原合成的良好催化剂,2,3-二-氯-5,6二氰基-1,4-苯醌是将卟啉原转化为卟啉的良好氧化剂;硝基卟啉经SnCl₂还原成氨基卟啉后,用固-液抽提进行氨基卟啉的纯化,得到了5,15-双(对-硝基苯基)-2,3,7,8,12,13,17,18-八甲基卟啉、5,15-双(对-氨基苯基)-2,3,7,8,12,13,17,18-八甲基卟啉及其金属衍生物,并表征了其结构     

一种新型α-甲氧基甲基吡咯的合成

以乙酰乙酸苄酯(4)为原料,经Knorr缩合制备了2,4-二甲基-3-丙酸甲酯基-5-羧酸苄酯基-1-氢吡咯(2)和2,4-二甲基-3-羧酸甲酯基-5-羧酸苄酯基-1-氢吡咯(3)。乙醚介质中,溴水氧化条件下,吡咯(2)发生自身缩合生成二吡咯甲烷(7),吡咯(3)无反应发生。在Pb(OAC)4氧化条件下,当其浓度为吡咯(3)浓度的2倍时,在80℃,吡咯(3)完全转化,所得产物经HCl甲醇溶液回流,以82%的产率制备了新型2-甲氧基甲基-3-羧酸甲酯基-4-甲基-5-羧酸苄酯基-1-氢吡咯(1)。吡咯(1)、(2)、(3)及二吡咯(7)的结构用核磁、元素分析、质谱和红外测试技术进行了表征。吡咯(1)的构建对进一步研究吡咯构效关系具有一定参考价值。     

2,2-二(4-羟基-3-氨基)苯基丙烷的合成

在乙醇介质中,以Fe(OH)3／C为催化剂,用80％水合肼将2,2-二(4-羟基-3-硝基)苯基丙烷还原为2,2-二(4-羟基-3-氨基)苯基丙烷。产率99．0％,纯度98．5％。考察了10种金属离子对催化剂活性的影响,结果发现Pb^2 会引起催化剂中毒;Mg^2 ,Cu^2 和Zn^2 钝化了催化剂的催化活性;Ba^2 和Cr^3 不影响催化剂的活性;Al^3 ,Ni^2 ,Ti^3 和Ti^4 能活化催化剂,使反应速度加快,但它们单独使用时无催化活性。     

离子液体介质中一锅法合成2-氨基-4-苯基-6-(苯基硫基)-3,5-二氰基吡啶衍生物

考察了各种不同介质中,芳醛、丙二腈和苯硫酚为原料的一锅反应,发现在离子液体1-正丁基-3-甲基咪唑四氟硼酸盐([bmim]BF4)介质中,反应能够在较短时间内高产率地生成2-氨基-4-苯基-6-(苯基硫基)-3,5-二氰基吡啶衍生物,且没有1,4-二氢吡啶副产物的生成.该方法具有反应条件温和、产率高、选择性好和环境友好等优点,且离子液体容易回收,可循环使用.     

一种新型α-甲醚基吡咯的合成

以乙酰乙酸苄酯(4)为原料, 经Knorr缩合制备了2,4-二甲基-3-丙酸甲酯基-5-羧酸苄酯基-1-氢吡咯 (2) 和2,4-二甲基-3-羧酸甲酯基-5-羧酸苄酯基-1-氢吡咯(3)。乙醚介质中,溴水氧化条件下,吡咯 (2) 发生自身缩合生成二吡咯甲烷 (7),吡咯 (3)无反应发生。在Pb(OAC)₄氧化条件下,当其浓度为吡咯 (3)浓度的2倍时,在80 ℃,吡咯 (3) 完全转华。所得产物经HCl甲醇溶液回流,以82%的产率制备了新型2-甲氧基甲基-3-羧酸甲酯基-4-甲基-5-羧酸苄酯基-1氢吡咯 (1)。吡咯(1)、(2)、(3)及二吡咯(7)的结构用核磁、元素分析、质谱和红外等测试技术进行了表征。吡咯(1)的构建对进一步研究吡咯构效关系具有一定参考价值。     

1-[2′,4′-二氟-(1,1′-联苯)-4-基苯基甲基]-咪唑的合成

以2,4-二氟联苯为起始原料,经酰化反应制得2′,4′-二氟-(1,1′-联苯)-4-基苯基甲酮(2);2经NaBH4还原得2′,4′-二氟-(1,1′-联苯)-4-基苯基甲醇(3);3经氯代得2′,4′-二氟-(1,1′-联苯)-4-基苯基氯甲烷(4);4与咪唑发生亲核取代反应合成了1-[2′,4′-二氟-(1,1′-联苯)-4-基苯基甲基]-咪唑(5). 2～5为新化合物,其结构经1H NMR, IR, MS和元素分析确证.     

利用Pummerer反应合成2-(2,6-二卤苯基)-3-(4,5,6-三甲基-2-嘧啶基)-5-酯酰氧基-1,3-噻唑烷-4-酮衍生物

利用Pummerer反应,以有机酸为反应原料、溶剂和催化剂,简便、高效地合成了一系列2-(2,6-二卤苯基)-3-(4,5,6-三甲基-2-嘧啶基)-5-酯酰氧基-1,3-噻唑烷-4-酮(7a～7g和8a～8g),产率为62%～85%.X衍射确证化合物主要异构体的构型为噻唑烷-4-酮环C-5与C-2位取代基处于反式构型,顺反异构体比例通过1H NMR确定.化合物7a和8a具有中等强度的抗HIV-RT活性.     

超声技术合成1,5-二-(4-羟基苯基)-1,4-戊二烯-3-酮

利用对羟基苯甲醛和丙酮为原料,以氯化氢气体为催化剂,超声波辐射下成功合成了1,5-二-(4-羟基苯基)-1,4-戊二烯3-酮(HPD).与传统方法相比,该方法具有反应时间短,操作简便及产率高等优点,并讨论了影响产率的因素.     

PDMS-glass hybrid microreactor array with embedded temperature control device. Application to cell-free protein synthesis

A microreactor array was developed which enables high-throughput cell-free protein synthesis. The microreactor array is composed of a temperature control chip and a reaction chamber chip. The temperature control chip is a glass-made chip on which temperature control devices, heaters and temperature sensors, are fabricated with an ITO (indium tin oxide) resistive material. The reaction chamber chip is fabricated by micromolding of PDMS (polydimethylsiloxane), and is designed to have an array of reaction chambers and flow channels for liquid introduction. The microreactor array is assembled by placing the reaction chamber chip on the temperature control chip. The small thermal mass of the reaction chamber resulted in a short thermal time constant of 170 ms for heating and 3 s for cooling. The performance of the microreactor array was examined through the experiments of cell-free protein synthesis. By measuring the fluorescence emission from the products, it was confirmed that GFP (Green Fluorescent Protein) and BFP (Blue Fluorescent Protein) were successfully synthesized using Escherichia coli extract.     

Evaluation of cell-free protein synthesis using PDMS-based microreactor arrays.

A living cell has numerous proteins, only a few thousand of which have been identified to date. Cell-free protein synthesis is a useful and promising technique to discover and produce various proteins that might be beneficial for biotechnological, pharmaceutical, and medical applications. For this study, we evaluated the performance and the general applicability of our previously developed microreactor array chip to cell-free protein synthesis by comparisons with a commercially available system. The microreactor array chip comprises a temperature control chip made of glass and a disposable reaction chamber chip made of polydimethylsiloxane (PDMS). For evaluation of the microreactor array chip, rat adipose-type fatty acid binding protein, glyceraldehyde-3-phosphate dehydrogenase, cyclophilin, and firefly luciferase were synthesized from their respective DNA templates using a cell-free extract prepared from Escherichia coli. All these proteins were synthesized in the microreactor array chip, and their respective amounts and yields were investigated quantitatively.     

Convenient Synthesis of 2, 5-Dimethyl-2-Furoic Acid

A synthesis of 4, 5-dimethyl-2-furoic acid amenable to large scale is reported affording the titled compound in 25% yield.     

An alternative route to the proline derivative (2S,5R)-5-ethoxycarbonylmethyl-pyrrolidine-2-carboxylic acid from protected glutamic acid

The synthesis of (2S,5R)-5-ethoxycarbonylmethyl-pyrrolidine-2-carboxylic acid was achieved in two steps, with an overall yield of 53%. This synthesis used Cbz-Glu-OBzl as the starting material and led to the titled compound with a d.e.>96%.     

Bone collagen cross-links: a convergent synthesis of (+)-deoxypyrrololine.

A convergent total synthesis of (+)-deoxypyrrololine (Dpl, 4), a putative cross-link of bone collagen, is described starting from a commercially available L-glutamic acid derivative, (4S)-5-(tert-butoxy)-4-[(tert-butoxycarbonyl)amino]-5- oxopentanoic acid (16). Condensation of aldehyde (S)-(-)-17 with nitro compound (S)-(-)-27, both of which were prepared from a common precursor (S)-16, gave the alpha-hydroxynitro compound 28, which upon acetylation afforded alpha-acetoxynitro compound 14 in good yield. Subsequent condensation and cyclization of alpha-acetoxynitro compound 14 with benzyl isocyanoacetate (15) in the presence of DBU in THF gave the key pyrrole intermediate (S,S)-(-)-12 in 57% yield. N-Alkylation of pyrrole (S,S)-(-)-12 with iodide (S)-(-)-13 using t-BuOK in THF afforded the 2-benzyloxycarbonyl-1,3,4-substituted pyrrole derivative (-)-29 in 42% yield. Removal of the protective groups in (-)-29 followed by hydrogenolysis and decarboxylation afforded the cross-link (+)-Dpl (4) in good overall yield. The synthesis of an analogue (S)-(+)-24 and formation of a novel tetrahydroindole derivative (-)-31 are also described.     

Multistage Microfluidic Platform for the Continuous Synthesis of III–V Core/Shell Quantum Dots

We present a fully continuous chip microreactor‐based multistage platform for the synthesis of quantum dots with heterostructures. The use of custom‐designed chip reactors enables precise control of heating profiles and flow distribution across the microfluidic channels while conducting multistep reactions. The platform can be easily reconfigured by reconnecting the differently designed chip reactors allowing for screening of various reaction parameters during the synthesis of nanocrystals. III–V core/shell quantum dots are chosen as model reaction systems, including InP/ZnS, InP/ZnSe, InP/CdS and InAs/InP, which are prepared in flow using a maximum of six chip reactors in series.     

Utility of the ammonia-free Birch reduction of electron-deficient pyrroles: total synthesis of the 20s proteasome inhibitor, clasto-lactacystin beta-lactone

A new synthesis of the 20S proteasome inhibitor clasto-lactacystin beta-lactone is described. Our route to this important natural product involves the partial reduction of an electron deficient pyrrole as a key step. By judicious choice of enolate counterion, we were able to exert complete control over the stereoselectivity of the reduction/aldol reaction. Early attempts to complete the synthesis by using a C-4 methyl substituted pyrrole are described in full, together with our attempts to promote regioselective elimination of a tertiary alcohol. The lessons learnt from this first approach led us to develop another, and ultimately successful, route that introduced the C-4 methyl group at a late stage in the synthesis. Our successful route is then described and this contains several highly stereoselective steps including a cis-dihydroxylation and an enolate methylation. The final synthesis proceeds in just 13 steps and in 15 % overall yield making it an extremely efficient route to this valuable compound.     

An efficient chemoenzymatic approach to (S)-gamma-fluoroleucine ethyl ester

[reaction: see text] An asymmetric synthesis of (S)-gamma-fluoroleucine ethyl ester 1 is described. The key transformation involves a lipase-catalyzed dynamic ring-opening of 2-(3-butenyl)azlactone 7b with EtOH to give amide ester (S)-6b in 84% enantiomeric excess. Removal of the N-pentenoyl group with N,N'-dibromodimethylhydantoin in the presence of trifluoroacetic acid afforded the titled compound, which was isolated as its hydrogen sulfate salt in 75% yield and >97% ee.     

Fused-s-triazino heterocycles. XII. 13H-4,6,7,8,13a, 13c-hexaazabenzo-[de]naphthacene,a new ring system

The synthesis of the titled compound is described using 5-(2-carboxyanilino)-2-methyl-1,3-4,6,9b-pentaaza-phenalene as starting material.     

Synthesis of directly linked diazine isosteres of pyrrole-polyamide that photochemically cleave DNA

A distamycin model containing an isosteric diazine linked pyrrole has been designed and synthesized. The key steps of the synthesis involved the successful diazotization of the 4-amino-pyrrole derivatives to give the diazomium salts, which undergo coupling reactions with N-methylpyrrole to yield the directly linked diazine compounds. The amide isosteric-diazine pyrrole I demonstrated photo-induced DNA damage upon iradiation with UV light (365 nm). Spectrophotometric and mass spectrometric identification suggest that the azo-linkage in I did not dissociate during irradiation. Moreover, compound I produced DNase I footprints with the HexB DNA fragment at AT sites, as well as some other mixed sequences (5'-ATGTCG-3'), indicative of the additional role of the diazine-linkage for interaction at the duplex DNA.